Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Innate Pharma    IPH   FR0010331421

INNATE PHARMA

(IPH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on INNATE PHARMA
2020INNATE PHARMA S A : SVB Leerink Downgrades Innate Pharma to Market Perform From ..
MT
2020INNATE PHARMA S A : HC Wainwright Adjusts Innate Pharma's Price Target to $11.50..
MT
2020Goldman Sachs Starts Innate Pharma at Neutral With $4.75 Price Target
MT
2015France's 'economic patriotism' is not what it seems
RE
Official Publications
01/11Corporate Officers and Executives' transac.. 
01/07Corporate Officers and Executives' transac.. 
01/07Corporate Officers and Executives' transac.. 
01/07Corporate Officers and Executives' transac.. 
01/01Corporate Officers and Executives' transac.. 
01/01Corporate Officers and Executives' transac.. 
Upcoming event on INNATE PHARMA
03/18/21Jahr 2020 Ergebnisveröffentlichung
Upcoming sector events
01/27/21LONZA GROUP LTD : FY 2020 Earnings Release
02/01/21VERTEX PHARMACEUTICALS INCORPORATED : FY 2020 Earnings Release
02/02/21BIO-TECHNE CORPORATION : Interim 2021 Earnings Release
02/03/21QIAGEN N.V. : FY 2020 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers The best of tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2021 Surperformance. All rights reserved. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ